ChinaAnimal Healthcare

ChinaAnimal Healthcare: AmFraser has Buy call with $0.39 target. Notes "stamp of approval" by Blackstone increases CAH’s profile among global fund managers, may aid company in raising fresh funds in HK. But deal has not been concluded and there is uncertainty regarding the exact amount of dilution at this juncture. Stock flat at $0.315 in thin trade as interest wanes after yesterday's run-up on strong volume to 3-mth high of $0.335.